Viromed Medical AG: Changes to the Management Board
Published on 11/16/2026 at 17:57 | dgap, AD HOC NEWS| EQS-Ad-hoc: Viromed Medical AG / Key word(s): Personnel decisions / Executive Board 16-Nov-2026 / 17:57 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Rellingen, November 16, 2026 – The Supervisory Board of Viromed Medical AG (“Viromed”; ISIN: DE000A40ZVN7) today resolved to appoint Christian Strauch to the Management Board of the company. Mr. Strauch assumes the position effective today, for a term of just under three years, until the end of October 31, 2029. Christian Strauch has more than twenty years of experience in building and in scaling companies in the healthcare sector. At the same time, Uwe Perbandt, founder of Viromed Medical AG, has today resigned from his position on the Management Board, effective as of the end of December 31, 2026, for personal reasons. Notifying person: Uwe Perbandt, CEO of Viromed Medical AG Contact Viromed: E-mail: kontakt@viromed-medical.de End of Inside Information 16-Nov-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News |
| Language: | English |
| Company: | Viromed Medical AG |
| Hauptstraße 105 | |
| 25462 Rellingen | |
| Germany | |
| E-mail: | kontakt@viromed-medical.de |
| Internet: | https://www.viromed-medical-ag.de/ |
| ISIN: | DE000A40ZVN7 |
| WKN: | A40ZVN |
| Listed: | Regulated Unofficial Market in Dusseldorf, Frankfurt, Hamburg, Tradegate BSX |
| LEI Code: | 894500XR05MYCVCCR171 |
| EQS News ID: | 2436132 |
| End of Announcement | EQS News Service |
| |
2436132 16-Nov-2026 CET/CEST
en | DE000A40ZVN7 | VIROMED MEDICAL AG | boerse | 70521923 |
